Vuno Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 166

Employees

  • Stock Symbol
  • 338220

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $4.10
  • (As of Friday Closing)

Vuno General Information

Description

Vuno Inc is engaged in the business of manufacturing medical devices and equipment. The company develops and markets bone age testing equipment, brain quantification medical device, X-ray reading aid solutions, imaging devices, and other related devices.

Contact Information

Website
www.vuno.co
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 9th floor, 479, Gangnam-daero
  • Seocho-gu
  • Seoul
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Stock Exchange
KRX
Vertical(s)
Manufacturing, SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 9th floor, 479, Gangnam-daero
  • Seocho-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vuno Stock Performance

As of 13-Nov-2026, Vuno’s stock price is $4.10. Its current market cap is $57.4M with 14M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.10 $4.12 $3.07 - $19.29 $57.4M 14M 269K -$0.54

Vuno Financials Summary

As of 30-Jun-2026, Vuno has a trailing 12-month revenue of $20.8M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 50,322 207,707 227,261 370,442
Revenue 20,821 24,487 18,960 10,154
EBITDA (6,116) (2,630) (8,063) (10,537)
Net Income (7,613) (4,061) (9,541) (11,952)
Total Assets 31,073 34,992 34,069 17,503
Total Debt 3,920 5,314 7,771 8,413
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vuno Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vuno‘s full profile, request access.

Request a free trial

Vuno Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Vuno Inc is engaged in the business of manufacturing medical devices and equipment. The company develops and markets bon
Decision/Risk Analysis
Seoul, South Korea
166 As of 2025

Beijing, China
 

Deerfield, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vuno Competitors (23)

One of Vuno’s 23 competitors is Infervision, a Venture Capital-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Infervision Venture Capital-Backed Beijing, China
Baxter International Corporation Deerfield, IL
SigTuple Venture Capital-Backed Bengaluru, India
Philips Corporation Amsterdam, Netherlands
MedyMatch Technology Venture Capital-Backed Tel Aviv, Israel
You’re viewing 5 of 23 competitors. Get the full list »

Vuno Patents

  • 242

    Total Documents Applications and Grants

  • Total Patents Families

  • 111

    Granted

  • 57

    Pending

  • Expiring in next 12 mo

Vuno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026216909-A1 Method for generating electrocardiogram signal Pending 08-Apr-2025
WO-2026187045-A1 Method for identifying lesion location in medical image Pending 05-Mar-2025
WO-2026160732-A1 Electrocardiogram signal processing method Pending 24-Jan-2025
WO-2026160738-A1 Electrocardiogram signal processing method Pending 24-Jan-2025
WO-2026160731-A1 Electrocardiogram data augmentation method Pending 21-Jan-2025
To view Vuno’s complete patent history, request access »

Vuno Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vuno Investments (3)

Vuno’s most recent deal was a Later Stage VC with DenComm (Enterprise Systems) for . The deal was made on 10-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DenComm (Enterprise Systems) 10-Nov-2022 Later Stage VC Enterprise Systems (Healthcare)
Puzzle AI 15-May-2022 Early Stage VC Medical Records Systems
Oncosoft 01-Jun-2021 Early Stage VC Decision/Risk Analysis
To view Vuno’s complete investments history, request access »

Vuno ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Software & Services

Industry

Rank

Percentile

Enterprise and Infrastructure Software

Subindustry

Rank

Percentile

To view Vuno’s complete esg history, request access »

Vuno FAQs

  • When was Vuno founded?

    Vuno was founded in 2014.

  • Where is Vuno headquartered?

    Vuno is headquartered in Seoul, South Korea.

  • What is the size of Vuno?

    Vuno has 166 total employees.

  • What industry is Vuno in?

    Vuno’s primary industry is Decision/Risk Analysis.

  • Is Vuno a private or public company?

    Vuno is a Public company.

  • What is Vuno’s stock symbol?

    The ticker symbol for Vuno is 338220.

  • What is the current stock price of Vuno?

    As of 13-Nov-2026 the stock price of Vuno is $4.10.

  • What is the current market cap of Vuno?

    The current market capitalization of Vuno is $57.4M.

  • What is Vuno’s current revenue?

    The trailing twelve month revenue for Vuno is $20.8M.

  • Who are Vuno’s competitors?

    Infervision, Baxter International, SigTuple, Philips, and MedyMatch Technology are some of the 23 competitors of Vuno.

  • What is Vuno’s annual earnings per share (EPS)?

    Vuno’s EPS for 12 months was -$0.54.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process